Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 3, 2026 · Contract termination · Investor press release
Cardiff Oncology, Inc.
32
Contract termination
Jun 3, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Contract termination · Investor press release |
| Primary topic | Contract termination |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Cardiff Oncology, Inc. filed this to report entering into or terminating a material contract that could affect operations, partnerships, or future hiring. |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 3, 2026 |
| Accession number | 0001193125-26-254658 |
| Reported items | Terminated a material definitive agreement, Regulation FD disclosure (investor press release or presentation) See Analysis tab for workforce implications |
